
Topic
Manufacturing Capacity
Drug substance, fill-finish, CDMO bottlenecks, inspections, tech transfer, and capacity as a commercial constraint.

Manufacturing· May 22, 2026 · 10 min read
By Ran Chen#Manufacturing Capacity#CMC#FDA Approval

Manufacturing· May 22, 2026 · 14 min read
CMC-only complete response letters: how commercial teams should read the risk
By Ran Chen#Manufacturing Capacity#CMC#FDA Approval

Manufacturing· May 22, 2026 · 12 min read
Global CMC change classification mismatch between FDA, EMA, and non-ICH markets
By Ran Chen#CMC#Post-Approval Changes#ICH

Manufacturing· May 22, 2026 · 11 min read
PACMP strategy for a planned biologic manufacturing site change

Manufacturing· May 22, 2026 · 10 min read
PAI readiness for a launch-critical facility when approval timing is tight

Manufacturing· May 22, 2026 · 15 min read
Stability out-of-trend signals that can quietly derail launch supply
By Ran Chen#CMC#Manufacturing Capacity#Regulatory

Manufacturing· May 22, 2026 · 12 min read
Tech-transfer package gaps before moving a commercial product to a second site

Manufacturing· May 9, 2026 · 4 min read